English
Home > Products > 116539-55-0

China 116539-55-0 Factory

With our superb management, potent technical capability and strict quality command procedure, we go on to provide our shoppers with trustworthy high-quality, reasonable costs and outstanding services. We goal at becoming considered one of your most trustworthy partners and earning your pleasure for 116539-55-0,CAS NO 116539-55-0,Duloxetine intermediate,Duloxetine advance intermediate,(S)-3-(MethylaMino)-1-(2-thienyl)-1-propanol, We invites both you and your enterprise to thrive along with us and share a vibrant long term in global sector.
116539-55-0, We've exported our solutions all over the world, especially the USA and European countries. Furthermore, all of our merchandise are manufactured with advanced equipment and strict QC procedures to ensure high quality.If you are interested in any of our products and solutions, please don't hesitate to contact us. We are going to try our best to meet your needs.

Related Products

Hot Products

  • (2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE

    (2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE

    Product Name:(2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE
    Molecular Formula:C10H11F2N
    Molecular Weight:183.2
    CAS Registry Number:1218935-59-1
  • Relebactam

    Relebactam

    Product Name:Relebactam
    Molecular Formula:C12H20N4O6S
    Molecular Weight;348.38
    CAS Registry Number;1174018-99-5
  • Allopurinol

    Allopurinol

    Product Name:Allopurinol
    Molecular Formula:C5H4N4O
    Molecular Weight;136.11
    CAS Registry Number;315-30-0
  • 1,1-Dimethylpropargylamine

    1,1-Dimethylpropargylamine

    Product Name:1,1-Dimethylpropargylamine
    Molecular Formula:C5H9N
    Molecular Weight:83.13
    CAS Registry Number:2978-58-7
  • Ramipril

    Ramipril

    Product Name:Ramipril
    Molecular Formula:C23H32N2O5
    Molecular Weight;416.51
    CAS Registry Number;87333-19-5
  • Maytansinol

    Maytansinol

    Product Name:Maytansinol
    Molecular Formula:C28H37ClN2O8
    Molecular Weight;565.05
    CAS Registry Number;57103-68-1
  • Related Blog
  • Reviews

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 116539-55-0

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept